Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1933229 | 0.83 | GAA (0.47) | KDM4EGAAKMT2AMAPK8 | |
| SCHEMBL20313798 | 0.76 | MAOB (0.34) | KDM4EGAAKMT2A | |
| SCHEMBL12352252 | 0.72 | GAA (0.50) | KDM4EGAAKMT2AMAPK8 | |
| SCHEMBL2302254 | 0.71 | GAA (0.50) | KDM4EGAAKMT2AMAPK8 | |
| SCHEMBL26082900 | 0.71 | MAOB (0.36) | KDM4EGAAKMT2A | |
| SCHEMBL1933227 | 0.71 | MAOB (0.48) | KDM4EGAAKMT2A | |
| SCHEMBL12786289 | 0.69 | GAA (0.48) | KDM4EGAAKMT2AMAPK8 | |
| SCHEMBL4900433 | 0.69 | GAA (0.48) | KDM4EGAAKMT2AMAPK8 | |
| SCHEMBL11942300 | 0.68 | GAA (0.44) | KDM4EGAAKMT2AMAPK8 | |
| SCHEMBL1463814 | 0.68 | GAA (0.47) | KDM4EGAAKMT2AMAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | HNRNPU, CBR1, CBR3 | KDM4E 2890/4885GAA 4805/4885KMT2A 2525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.